Literature DB >> 35093949

Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.

Christopher A Legare1, Wesley M Raup-Konsavage1, Kent E Vrana1.   

Abstract

BACKGROUND: There is a growing interest in the use of cannabis (and its extracts), as well as CBD oil (hemp extracts containing cannabidiol), for therapeutic purposes. While there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited objective data supporting the use of crude materials (CBD oil, cannabis extracts, and/or cannabis itself).
SUMMARY: In the present review, we examined data for pure cannabinoid compounds (dronabinol, nabilone, and CBD), as well as partially purified medicinal cannabis extracts (nabiximols), to provide guidance on the potential therapeutic uses of high-THC cannabis and CBD oil. In general, data support a role for cannabis/cannabinoids in pain, seizure disorders, appetite stimulation, muscle spasticity, and treatment of nausea/vomiting. Given the biological activities of the cannabinoids, there may be utility in treatment of central nervous system disorders (such as neurodegenerative diseases, PTSD, and addiction) or for the treatment of cancer. However, those data are much less compelling. Key Message: On balance, there are reasons to support the potential use of medical cannabis and cannabis extract (Δ9-THC-dominant or CBD-dominant), but much more careful research is required.
© 2022 S. Karger AG, Basel.

Entities:  

Keywords:  CBD; Cannabinoids; Cannabis; Medical marijuana; Pharmacology; Therapeutics; Δ9-THC

Mesh:

Substances:

Year:  2022        PMID: 35093949     DOI: 10.1159/000521683

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  7 in total

1.  Oleamide Reduces Mitochondrial Dysfunction and Toxicity in Rat Cortical Slices Through the Combined Action of Cannabinoid Receptors Activation and Induction of Antioxidant Activity.

Authors:  Carolina Y Reyes-Soto; Mariana Villaseca-Flores; Enid A Ovalle-Noguez; Jade Nava-Osorio; Sonia Galván-Arzate; Edgar Rangel-López; Marisol Maya-López; Socorro Retana-Márquez; Isaac Túnez; Alexey A Tinkov; Tao Ke; Michael Aschner; Abel Santamaría
Journal:  Neurotox Res       Date:  2022-09-07       Impact factor: 3.978

2.  Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine.

Authors:  Davide Fortin; Fabienne Marcellin; Patrizia Carrieri; Julien Mancini; Tangui Barré
Journal:  Front Public Health       Date:  2022-05-27

Review 3.  Medical cannabis regulation: an overview of models around the world with emphasis on the Brazilian scenario.

Authors:  Maíra Ribeiro de Souza; Amélia Teresinha Henriques; Renata Pereira Limberger
Journal:  J Cannabis Res       Date:  2022-06-16

4.  A Case Report of Subcutaneously Injected Liposomal Cannabidiol Formulation Used as a Compassion Therapy for Pain Management in a Dog.

Authors:  Yael Shilo-Benjamini; Ahuva Cern; Daniel Zilbersheid; Atara Hod; Eran Lavy; Dinorah Barasch; Yechezkel Barenholz
Journal:  Front Vet Sci       Date:  2022-04-28

5.  The Determination of Cannabinoids in Urine Samples Using Microextraction by Packed Sorbent and Gas Chromatography-Mass Spectrometry.

Authors:  Luana M Rosendo; Tiago Rosado; Patrik Oliveira; Ana Y Simão; Cláudia Margalho; Suzel Costa; Luís A Passarinha; Mário Barroso; Eugenia Gallardo
Journal:  Molecules       Date:  2022-08-27       Impact factor: 4.927

Review 6.  Review: Cannabinoids as Medicinals.

Authors:  Jag H Khalsa; Gregory Bunt; Kenneth Blum; Sanjay B Maggirwar; Marc Galanter; Marc N Potenza
Journal:  Curr Addict Rep       Date:  2022-09-07

7.  Neurogenetic and Epigenetic Aspects of Cannabinoids.

Authors:  Catherine A Dennen; Kenneth Blum; Abdalla Bowirrat; Jag Khalsa; Panayotis K Thanos; David Baron; Rajendra D Badgaiyan; Ashim Gupta; Eric R Braverman; Mark S Gold
Journal:  Epigenomes       Date:  2022-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.